AAAAAA

   
Results: 1-11 |
Results: 11
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line
Authors: Wall, NR Beck, FWJ Al-Katib, AM Mohammad, RM
Citation: Nr. Wall et al., Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line, J DRUG TAR, 9(5), 2001, pp. 329-339
Zinc activates NF-kappa B in HUT-78 cells
Authors: Prasad, AS Bao, B Beck, FWJ Sarkar, FH
Citation: As. Prasad et al., Zinc activates NF-kappa B in HUT-78 cells, J LA CL MED, 138(4), 2001, pp. 250-256
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells
Authors: Beck, FWJ Al-Katib, AM Ahmad, I Wall, NR Liu, KZ Mantsch, HH Mohammad, RM
Citation: Fwj. Beck et al., Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells, INT J MOL M, 5(4), 2000, pp. 341-347
Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: Case report
Authors: Ahmad, I Al-Katib, AM Beck, FWJ Mohammad, RM
Citation: I. Ahmad et al., Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: Case report, CLIN CANC R, 6(4), 2000, pp. 1328-1332
Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate - A randomized, double-blind, placebo-controlled trial
Authors: Prasad, AS Fitzgerald, JT Bao, B Beck, FWJ Chandrasekar, PH
Citation: As. Prasad et al., Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 133(4), 2000, pp. 245-252
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model
Authors: Mohammad, RM Limvarapuss, C Wall, NR Hamdy, N Beck, FWJ Pettit, GR Al-Katib, A
Citation: Rm. Mohammad et al., A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model, INT J ONCOL, 15(2), 1999, pp. 367-372
Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine
Authors: Mohammad, RM Limvarapuss, C Hamdy, N Dutcher, BS Beck, FWJ Wall, NR Al-Katib, AM
Citation: Rm. Mohammad et al., Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine, INT J ONCOL, 14(5), 1999, pp. 945-950
Zinc status and interleukin-2 production in cystic fibrosis
Authors: Abdulhamid, I Kassab, JT Beck, FWJ Kaplan, J Prasad, AS
Citation: I. Abdulhamid et al., Zinc status and interleukin-2 production in cystic fibrosis, J TR EL EXP, 12(1), 1999, pp. 15-23
Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line
Authors: Liu, KZ Schultz, CP Johnston, JB Beck, FWJ Al-Katib, AM Mohammad, RM Mantsch, HH
Citation: Kz. Liu et al., Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line, LEUKEMIA, 13(8), 1999, pp. 1273-1280
Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD) (vol 61, pg 194, 1999)
Authors: Prasad, AS Beck, FWJ Kaplan, J Chandrasekar, PH Ortega, J Fitzgerald, JT Swerdlow, P
Citation: As. Prasad et al., Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD) (vol 61, pg 194, 1999), AM J HEMAT, 62(2), 1999, pp. 127-127
Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD)
Authors: Prasad, AS Beck, FWJ Kaplan, J Chandrasekar, PH Ortega, J Fitzgerald, JT Swerdlow, P
Citation: As. Prasad et al., Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD), AM J HEMAT, 61(3), 1999, pp. 194-202
Risultati: 1-11 |